InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Neil Falkingham, PCA of Lynn Baxter (President, Europe). Director active across 1 company, notably GSK plc. Cumulatively, 1 filings have been published. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Declarations1 total
14 shares@ £18.7780.0000% mcap100.0% of flowLondon Stock Exchange (XLON)RNS:9569357-8
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About Neil Falkingham
Neil Falkingham is the Chairman of the PCA of Lynn Baxter (President, Europe) at GSK plc, a global healthcare company. In his role, Neil oversees operations in Europe and contributes to the company's overall strategy. His expertise in management and business development is essential for GSK.
